Register

Support: 888-992-3836|NewsWire|Home|Login / Register

Home > Boards > US Listed > Medical - Drugs > Stealth BioTherapeutics Corp (MITO)

B/A 1.54X1.55 ARCA on both sides

Public Reply | Private Reply | Keep | Last Read

Next 10 | Previous | Next

[SMART MONEY] Member Level

Member Level

Followed By	3,589
Posts	135,892
Boards Moderated	17
Alias Born	08/05/09

160x600 placeholder

Stealth BioTherapeutics to Participate in Upcoming January Investor Conferences PR Newswire (US) - 1/7/2021 4:30:00 PM

Stealth BioTherapeutics Granted Pre-NDA Meeting For Elamipretide As A Treatment For Cardiomyopathy In Barth Syndrome PR Newswire (US) - 1/5/2021 8:00:00 PM

Stealth BioTherapeutics Announces Elamipretide Clinical Data to be Presented at the 13th International Conference on Cachexia... PR Newswire (US) - 12/9/2020 4:30:00 PM

Stealth BioTherapeutics Announces Appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors PR Newswire (US) - 12/7/2020 8:00:00 AM

Stealth BioTherapeutics Announces Closing of $3.2 Million Registered Direct Offering PR Newswire (US) - 11/24/2020 4:30:00 PM

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/23/2020 4:06:38 PM

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/20/2020 4:41:25 PM

Stealth BioTherapeutics Announces $3.2 Million Registered Direct Offering PR Newswire (US) - 11/20/2020 8:00:00 AM

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/19/2020 5:24:56 PM

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/19/2020 5:17:17 PM

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/9/2020 5:27:00 PM

Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 11/9/2020 4:18:36 PM

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/5/2020 8:06:55 AM

Stealth BioTherapeutics Reports Third Quarter 2020 Financial Results And Recent Business Highlights PR Newswire (US) - 11/5/2020 7:30:00 AM

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/4/2020 5:19:34 PM

Stealth BioTherapeutics Announces Development Financing To Advance Elamipretide Clinical Trials PR Newswire (US) - 11/4/2020 5:00:00 PM

Stealth BioTherapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 PR Newswire (US) - 10/30/2020 4:30:00 PM

Stealth BioTherapeutics Announces Poster Presentation at American Society of Human Genetics (ASHG) Virtual Annual Meeting PR Newswire (US) - 10/19/2020 4:30:00 PM

Stealth BioTherapeutics Announces Poster Presentation at 2020 Annual NEALS Meeting PR Newswire (US) - 9/23/2020 4:30:00 PM

Stealth BioTherapeutics to Present at Upcoming Investor Conferences in September PR Newswire (US) - 9/10/2020 5:30:00 PM

Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/7/2020 6:12:54 AM

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/7/2020 6:10:05 AM

Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/6/2020 8:00:59 AM

Stealth BioTherapeutics Reports Second Quarter 2020 Financial Results and Recent Business Highlights PR Newswire (US) - 8/6/2020 7:30:00 AM

Stealth BioTherapeutics to Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020 PR Newswire (US) - 7/30/2020 8:30:00 AM

[SMART MONEY]	Wednesday, 11/04/20 05:17:09 PM
Re: boston127 post# 1
Post # of 7

B/A 1.54X1.55 ARCA on both sides

and this govt thinks this is somewhow a fair and transparent market?

#ITSNOT

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions

Public Reply | Private Reply | Keep | Last Read

Next 10 | Previous | Next

Follow Board

Keyboard Shortcuts

Report TOS Violation

X


Current Price
Change
Volume
Detailed Quote - Discussion Board

+/- to Watchlist

Consent Preferences

Ticker News is disabled